Sekine Mai

セキネマイ | Sekine Mai

Affiliation and department：
Research theme for competitive and other funds (2)：

Papers (4)：

Mai Sekine, Megumi Fujiwara, Ken Okamoto, Kimiyoshi Ichida, Koji Nagata, Russ Hille, Takeshi Nishino. Significance and Amplification Methods of the Purine Salvage Pathway in Human Brain Cells. Journal of Biological Chemistry. 2024
Mai Sekine, Ken Okamoto, Emil F. Pai, Koji Nagata, Kimiyoshi Ichida, Russ Hille, Takeshi Nishino. Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase. Journal of Biological Chemistry. 2023
Yuki Ohashi, Kuriyama S, Nakano T, Sekine M, Yu Toyoda, Akiyoshi Nakayama, Takada T, Yusuke Kawamura, Nakamura T, Matsuo H, et al. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2022
Sekine M, Ken Okamoto, Ichida K. Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase. 2021

MISC (3)：

関根舞, 市田公美. 【腎臓症候群(第3版)-その他の腎臓疾患を含めて-】先天性・遺伝性腎疾患先天代謝異常キサンチン尿症. 日本臨床. 2022. 別冊. 腎臓症候群II. 77-82
関根舞, 市田公美. 【水・電解質を科学する】薬理学的基礎キサンチンオキシダーゼ阻害薬. 腎と透析. 2021. 90. 5. 786-791
関根舞, 市田公美. 【心血管疾患の残余リスクとしてのキサンチンオキシダーゼ(XO)】痛風・高尿酸血症治療薬の分類申請中の新規薬剤ドチヌラドの紹介も含めて. 循環器内科. 2020. 87. 1. 74-79

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page